The Relation Between Placental Volume at the 1st Trimester and Perinatal Prognosis

NCT05429242 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2023-04-25

No results posted yet for this study

Summary

It has been known for years that placental transport and endocrine and metabolic functions of the placenta are the main determinants of fetal nutrition and homeostasis. And placental capacity is roughly related to the weight of this organ. It has long been understood that placental weight at birth is also positively associated with birth weight. Since the 1970s, it has been possible to assess the size of the placenta in early pregnancy using two-dimensional (2D) ultrasonography (USG). Since then, it has been estimated that placental size is associated with fetal development. However, the difficulty in defining the required sonographic planes due to the technology of that time-limited the usefulness of this technique. As studies on this subject increase with the development of technology, it has now been shown that low placental volume at 11-13 weeks is associated with babies small for gestational age (SGA), fetal growth restriction, and preeclampsia. Pregnancy complications place a severe burden on the health system. Detection of these complications in the early period will prevent maternal and fetal mortality and morbidity. A relationship that predicts obstetric, fetal, and perinatal risks with placental thickness and width measurement with USG, a non-invasive method, in an early period such as the 1st trimester, will enable a proactive approach to complications. In our study, the investigators plan to present the perinatal results they obtained rather than investigating a specific relationship. The investigators think that the results of their study will make a profound contribution to the literature.

Conditions

  • Pregnancy Complications
  • Perinatal Problems
  • Maternal-Fetal Relations

Interventions

OTHER

Ultrasonographic examination

Measurement of placental volume at the first trimester of pregnancy by using ultrasound.

Sponsors & Collaborators

  • Siirt University

    lead OTHER

Principal Investigators

  • Şerif Aksin, Assoc.Prof · Siirt University Medical Faculty Obstetrics and Gynecology Departmant

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-11
Primary Completion
2023-04-15
Completion
2023-04-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05429242 on ClinicalTrials.gov